Unnamed: 0,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0097006,GO:0097006,regulation of plasma lipoprotein particle levels,7/27,84/18800,2.2755320663822798e-11,2.97639594282803e-08,1.44436403792476e-08,ADIPOQ/APOA1/APOC1/APOE/APOM/PCSK9/PLA2G7,7
GO:0010876,GO:0010876,lipid localization,10/27,446/18800,3.0032523905673403e-10,1.30941804228736e-07,6.35424979477932e-08,ACE/ADIPOQ/ANGPTL3/APOA1/APOC1/APOE/APOM/FABP1/PCSK9/REN,10
GO:0034368,GO:0034368,protein-lipid complex remodeling,5/27,30/18800,5.7397509143258e-10,1.50151883918763e-07,7.28646273965991e-08,APOA1/APOC1/APOE/APOM/PLA2G7,5
GO:0034369,GO:0034369,plasma lipoprotein particle remodeling,5/27,30/18800,5.7397509143258e-10,1.50151883918763e-07,7.28646273965991e-08,APOA1/APOC1/APOE/APOM/PLA2G7,5
GO:0006869,GO:0006869,lipid transport,9/27,391/18800,2.2357785916546504e-09,4.17771199697755e-07,2.0273300613049e-07,ACE/ADIPOQ/APOA1/APOC1/APOE/APOM/FABP1/PCSK9/REN,9
GO:0032368,GO:0032368,regulation of lipid transport,6/27,118/18800,1.42967093909865e-08,1.70000871667366e-06,8.24968015575582e-07,ADIPOQ/APOA1/APOC1/APOE/PCSK9/REN,6
GO:0034377,GO:0034377,plasma lipoprotein particle assembly,4/27,26/18800,4.93490360195932e-08,4.96527223950984e-06,2.40951163723196e-06,APOA1/APOC1/APOE/APOM,4
GO:0045834,GO:0045834,positive regulation of lipid metabolic process,6/27,153/18800,6.76808405151963e-08,6.32332424241977e-06,3.06853735568897e-06,ADIPOQ/ANGPTL3/APOA1/APOC1/APOE/FABP1,6
GO:1905952,GO:1905952,regulation of lipid localization,6/27,155/18800,7.31197436878897e-08,6.37604164958398e-06,3.09411968026649e-06,ADIPOQ/APOA1/APOC1/APOE/PCSK9/REN,6
GO:0065005,GO:0065005,protein-lipid complex assembly,4/27,29/18800,7.81705601117156e-08,6.39044328913275e-06,3.10110840443188e-06,APOA1/APOC1/APOE/APOM,4
GO:0010873,GO:0010873,positive regulation of cholesterol esterification,3/27,9/18800,2.20625557979956e-07,1.51883278861991e-05,7.3704826294689e-06,APOA1/APOC1/APOE,3
GO:0042632,GO:0042632,cholesterol homeostasis,5/27,98/18800,2.55946410526344e-07,1.67388952484229e-05,8.12293081828345e-06,ANGPTL3/APOA1/APOE/APOM/PCSK9,5
GO:0016042,GO:0016042,lipid catabolic process,7/27,327/18800,2.9745728305698e-07,1.76851875562968e-05,8.58214075039994e-06,ADIPOQ/ANGPTL3/APOA1/APOC1/APOE/FABP1/PLA2G7,7
GO:0030258,GO:0030258,lipid modification,6/27,216/18800,5.19252899149567e-07,2.95296866125058e-05,1.43299541504434e-05,ADIPOQ/APOA1/APOC1/APOE/FABP1/PLA2G7,6
GO:0015850,GO:0015850,organic hydroxy compound transport,6/27,248/18800,1.16392737943468e-06,5.35922087183692e-05,2.6006841990324e-05,APOA1/APOC1/APOE/APOM/PCSK9/REN,6
GO:0042157,GO:0042157,lipoprotein metabolic process,5/27,140/18800,1.50825257093466e-06,6.57598120927512e-05,3.1911449132407e-05,APOA1/APOC1/APOE/APOM/PCSK9,5
GO:0051004,GO:0051004,regulation of lipoprotein lipase activity,3/27,20/18800,2.96282222703172e-06,0.0001076492075821,5.22392340029277e-05,ANGPTL3/APOA1/APOC1,3
GO:0032805,GO:0032805,positive regulation of low-density lipoprotein particle receptor catabolic process,2/27,3/18800,5.9536122340227e-06,0.0001996749949256,9.68968468857136e-05,APOE/PCSK9,2
GO:0019217,GO:0019217,regulation of fatty acid metabolic process,4/27,92/18800,8.64589534936592e-06,0.0002629960724876,0.0001276248444471,ADIPOQ/APOA1/APOC1/FABP1,4
GO:0098801,GO:0098801,regulation of renal system process,3/27,33/18800,1.40045372117077e-05,0.000381623639019,0.0001851915776021,ACE/ADIPOQ/NPPB,3
GO:0016486,GO:0016486,peptide hormone processing,3/27,34/18800,1.5345116025762e-05,0.0004096206481978,0.0001987777650598,ACE/PLA2G7/REN,3
GO:0050727,GO:0050727,regulation of inflammatory response,6/27,394/18800,1.66262302089323e-05,0.0004349421822656,0.0002110656171786,ACE/ADIPOQ/APCS/APOA1/APOE/PLA2G7,6
GO:0048261,GO:0048261,negative regulation of receptor-mediated endocytosis,3/27,36/18800,1.82744878224522e-05,0.0004596736552262,0.0002230671286829,ADIPOQ/APOC1/PCSK9,3
GO:0003014,GO:0003014,renal system process,4/27,114/18800,2.02074810284476e-05,0.000498705380853,0.0002420081640546,ACE/ADIPOQ/NPPB/REN,4
GO:0032102,GO:0032102,negative regulation of response to external stimulus,6/27,429/18800,2.68661042130206e-05,0.0006067681973837,0.0002944481112364,ADIPOQ/APCS/APOA1/APOE/MMP12/RTN4R,6
GO:0032799,GO:0032799,low-density lipoprotein receptor particle metabolic process,2/27,6/18800,2.96889637863632e-05,0.0006067681973837,0.0002944481112364,APOE/PCSK9,2
GO:0010565,GO:0010565,regulation of cellular ketone metabolic process,4/27,132/18800,3.59507039050654e-05,0.0006915223633503,0.0003355770039435,ADIPOQ/APOA1/APOC1/FABP1,4
GO:0051005,GO:0051005,negative regulation of lipoprotein lipase activity,2/27,7/18800,4.15277078564422e-05,0.0007544200260587,0.000366099529787,ANGPTL3/APOC1,2
GO:0008203,GO:0008203,cholesterol metabolic process,4/27,139/18800,4.40051994252865e-05,0.0007884767239489,0.000382626319444,ANGPTL3/APOA1/APOE/PCSK9,4
GO:0032489,GO:0032489,regulation of Cdc42 protein signal transduction,2/27,8/18800,5.53212022510812e-05,0.0009586984885091,0.0004652303143175,APOA1/APOE,2
GO:1902652,GO:1902652,secondary alcohol metabolic process,4/27,149/18800,5.77050445951417e-05,0.0009802363419538,0.0004756820490891,ANGPTL3/APOA1/APOE/PCSK9,4
GO:0002002,GO:0002002,regulation of angiotensin levels in blood,2/27,9/18800,7.10642241633959e-05,0.0011335610390941,0.0005500863564894,ACE/REN,2
GO:0002016,GO:0002016,regulation of blood volume by renin-angiotensin,2/27,9/18800,7.10642241633959e-05,0.0011335610390941,0.0005500863564894,ACE/REN,2
GO:0034115,GO:0034115,negative regulation of heterotypic cell-cell adhesion,2/27,11/18800,0.0001083780093962,0.0016483539103526,0.0007999013423005,ADIPOQ/APOA1,2
GO:0070587,GO:0070587,regulation of cell-cell adhesion involved in gastrulation,2/27,11/18800,0.0001083780093962,0.0016483539103526,0.0007999013423005,ADIPOQ/APOA1,2
GO:0062012,GO:0062012,regulation of small molecule metabolic process,5/27,342/18800,0.0001123615604215,0.0016725587165781,0.0008116472767557,ADIPOQ/APOA1/APOC1/APOE/FABP1,5
GO:0050435,GO:0050435,amyloid-beta metabolic process,3/27,66/18800,0.0001138056007457,0.0016725587165781,0.0008116472767557,ACE/APOE/REN,3
GO:0008217,GO:0008217,regulation of blood pressure,4/27,183/18800,0.0001279680814787,0.0017704103884883,0.0008591320330423,ACE/ADIPOQ/NPPB/REN,4
GO:1900121,GO:1900121,negative regulation of receptor binding,2/27,13/18800,0.0001534274812021,0.0020271024789125,0.0009836977263675,ADIPOQ/PCSK9,2
GO:0043393,GO:0043393,regulation of protein binding,4/27,196/18800,0.000166627237478,0.0021367492806006,0.0010369063384855,ACE/ADIPOQ/APOE/PCSK9,4
GO:0032488,GO:0032488,Cdc42 protein signal transduction,2/27,15/18800,0.0002061712167609,0.0025202986123673,0.0012230324024284,APOA1/APOE,2
GO:0006631,GO:0006631,fatty acid metabolic process,5/27,395/18800,0.0002200875632745,0.0026240506072871,0.0012733804250717,ADIPOQ/ANGPTL3/APOA1/APOC1/FABP1,5
GO:0042180,GO:0042180,cellular ketone metabolic process,4/27,211/18800,0.0002210165007932,0.0026240506072871,0.0012733804250717,ADIPOQ/APOA1/APOC1/FABP1,4
GO:0001960,GO:0001960,negative regulation of cytokine-mediated signaling pathway,3/27,87/18800,0.000258368463483,0.0028884269250923,0.0014016750650496,ADIPOQ/APOA1/MMP12,3
GO:0060761,GO:0060761,negative regulation of response to cytokine stimulus,3/27,92/18800,0.0003046479125012,0.0032932187566248,0.0015981095366528,ADIPOQ/APOA1/MMP12,3
GO:1903035,GO:1903035,negative regulation of response to wounding,3/27,92/18800,0.0003046479125012,0.0032932187566248,0.0015981095366528,APCS/APOE/RTN4R,3
GO:0035813,GO:0035813,regulation of renal sodium excretion,2/27,20/18800,0.0003714225557511,0.0038557198644643,0.0018710760327313,ACE/NPPB,2
GO:0098869,GO:0098869,cellular oxidant detoxification,3/27,100/18800,0.0003892835240832,0.0039471538720998,0.0019154464710093,APOE/APOM/FABP1,3
GO:0006898,GO:0006898,receptor-mediated endocytosis,4/27,246/18800,0.000396202239253,0.0039864040687926,0.0019344935244503,ADIPOQ/APOC1/APOE/PCSK9,4
GO:0035812,GO:0035812,renal sodium excretion,2/27,22/18800,0.0004507723007919,0.0044000758913123,0.0021352372142775,ACE/NPPB,2
GO:0051051,GO:0051051,negative regulation of transport,5/27,464/18800,0.0004617477108737,0.004473822265355,0.0021710243248101,ACE/ADIPOQ/APOC1/APOE/PCSK9,5
GO:0044062,GO:0044062,regulation of excretion,2/27,24/18800,0.0005376318671842,0.0050591545487554,0.0024550701697243,ACE/NPPB,2
GO:0034114,GO:0034114,regulation of heterotypic cell-cell adhesion,2/27,25/18800,0.0005838651539494,0.005397327303624,0.0026191762144578,ADIPOQ/APOA1,2
GO:0097254,GO:0097254,renal tubular secretion,2/27,27/18800,0.0006819134612058,0.0062373622885125,0.0030268223563279,ACE/NPPB,2
GO:0001822,GO:0001822,kidney development,4/27,303/18800,0.0008663665097983,0.0076568067217311,0.0037156401522645,ACE/ADIPOQ/PCSK9/REN,4
GO:0044788,GO:0044788,modulation by host of viral process,2/27,32/18800,0.0009593595926106,0.0084217607190249,0.0040868515319266,APCS/APOE,2
GO:0035296,GO:0035296,regulation of tube diameter,3/27,141/18800,0.0010586511106922,0.0089105489602237,0.0043240471777039,ACE/APOE/NPPB,3
GO:0097746,GO:0097746,blood vessel diameter maintenance,3/27,141/18800,0.0010586511106922,0.0089105489602237,0.0043240471777039,ACE/APOE/NPPB,3
GO:0035150,GO:0035150,regulation of tube size,3/27,142/18800,0.0010804673365062,0.0089105489602237,0.0043240471777039,ACE/APOE/NPPB,3
GO:0015748,GO:0015748,organophosphate ester transport,3/27,145/18800,0.0011476209428575,0.00938180120786,0.0045527330825202,APOA1/APOC1/APOE,3
GO:0019934,GO:0019934,cGMP-mediated signaling,2/27,36/18800,0.0012142353565446,0.0098038262121015,0.0047575303443563,APOE/NPPB,2
GO:0098754,GO:0098754,detoxification,3/27,150/18800,0.0012653121789831,0.0101535480374846,0.0049272408390497,APOE/APOM/FABP1,3
GO:0072217,GO:0072217,negative regulation of metanephros development,1/27,1/18800,0.0014361702127665,0.010310235858391,0.0050032771789874,ADIPOQ,1
GO:0090731,GO:0090731,cellular response to very-low-density lipoprotein particle stimulus,1/27,1/18800,0.0014361702127665,0.010310235858391,0.0050032771789874,APOE,1
GO:0150200,GO:0150200,regulation of transport across blood-brain barrier,1/27,1/18800,0.0014361702127665,0.010310235858391,0.0050032771789874,APOE,1
GO:1905855,GO:1905855,positive regulation of heparan sulfate binding,1/27,1/18800,0.0014361702127665,0.010310235858391,0.0050032771789874,APOE,1
GO:1905860,GO:1905860,positive regulation of heparan sulfate proteoglycan binding,1/27,1/18800,0.0014361702127665,0.010310235858391,0.0050032771789874,APOE,1
GO:1905890,GO:1905890,regulation of cellular response to very-low-density lipoprotein particle stimulus,1/27,1/18800,0.0014361702127665,0.010310235858391,0.0050032771789874,APOE,1
GO:2000477,GO:2000477,regulation of metanephric glomerular visceral epithelial cell development,1/27,1/18800,0.0014361702127665,0.010310235858391,0.0050032771789874,ADIPOQ,1
GO:2000478,GO:2000478,positive regulation of metanephric glomerular visceral epithelial cell development,1/27,1/18800,0.0014361702127665,0.010310235858391,0.0050032771789874,ADIPOQ,1
GO:2000584,GO:2000584,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,1/27,1/18800,0.0014361702127665,0.010310235858391,0.0050032771789874,ADIPOQ,1
GO:2000590,GO:2000590,negative regulation of metanephric mesenchymal cell migration,1/27,1/18800,0.0014361702127665,0.010310235858391,0.0050032771789874,ADIPOQ,1
GO:0046434,GO:0046434,organophosphate catabolic process,3/27,157/18800,0.0014424871269767,0.010310235858391,0.0050032771789874,ANGPTL3/APOC1/PLA2G7,3
GO:0050892,GO:0050892,intestinal absorption,2/27,41/18800,0.0015734575425631,0.0111247700847169,0.0053985484959635,APOA1/FABP1,2
GO:0031952,GO:0031952,regulation of protein autophosphorylation,2/27,42/18800,0.0016506697085326,0.0115106772068765,0.0055858187314876,ACE/ADIPOQ,2
GO:0090207,GO:0090207,regulation of triglyceride metabolic process,2/27,42/18800,0.0016506697085326,0.0115106772068765,0.0055858187314876,APOA1/APOE,2
GO:0031589,GO:0031589,cell-substrate adhesion,4/27,364/18800,0.0017054229356592,0.0116181937491788,0.0056379935866367,ANGPTL3/APOA1/MMP12/VWC2,4
GO:0048286,GO:0048286,lung alveolus development,2/27,44/18800,0.0018104225828314,0.0121437576325308,0.0058930354518075,ACE/MMP12,2
GO:0043534,GO:0043534,blood vessel endothelial cell migration,3/27,175/18800,0.0019675614784575,0.0130638092072204,0.0063395114694623,APOA1/APOE/FGFBP1,3
GO:0002762,GO:0002762,negative regulation of myeloid leukocyte differentiation,2/27,49/18800,0.0022406607813319,0.0141583782704452,0.0068706760800566,ADIPOQ/APCS,2
GO:0018198,GO:0018198,peptidyl-cysteine modification,2/27,49/18800,0.0022406607813319,0.0141583782704452,0.0068706760800566,ACE/RAB6A,2
GO:0030308,GO:0030308,negative regulation of cell growth,3/27,186/18800,0.002340127612977,0.0147158024892978,0.0071411788999248,DCBLD2/NPPB/RTN4R,3
GO:0001935,GO:0001935,endothelial cell proliferation,3/27,194/18800,0.0026368371904387,0.0161828586127429,0.0078531013548076,APOA1/APOE/FGFBP1,3
GO:0002415,GO:0002415,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,1/27,2/18800,0.0028703541270308,0.0161828586127429,0.0078531013548076,PIGR,1
GO:0044269,GO:0044269,glycerol ether catabolic process,1/27,2/18800,0.0028703541270308,0.0161828586127429,0.0078531013548076,PLA2G7,1
GO:0044869,GO:0044869,negative regulation by host of viral exo-alpha-sialidase activity,1/27,2/18800,0.0028703541270308,0.0161828586127429,0.0078531013548076,APCS,1
GO:0044870,GO:0044870,modulation by host of viral glycoprotein metabolic process,1/27,2/18800,0.0028703541270308,0.0161828586127429,0.0078531013548076,APCS,1
GO:0044871,GO:0044871,negative regulation by host of viral glycoprotein metabolic process,1/27,2/18800,0.0028703541270308,0.0161828586127429,0.0078531013548076,APCS,1
GO:0060177,GO:0060177,regulation of angiotensin metabolic process,1/27,2/18800,0.0028703541270308,0.0161828586127429,0.0078531013548076,ACE,1
GO:0070994,GO:0070994,detection of oxidative stress,1/27,2/18800,0.0028703541270308,0.0161828586127429,0.0078531013548076,ADIPOQ,1
GO:1901502,GO:1901502,ether catabolic process,1/27,2/18800,0.0028703541270308,0.0161828586127429,0.0078531013548076,PLA2G7,1
GO:1903597,GO:1903597,negative regulation of gap junction assembly,1/27,2/18800,0.0028703541270308,0.0161828586127429,0.0078531013548076,ACE,1
GO:1904905,GO:1904905,negative regulation of endothelial cell-matrix adhesion via fibronectin,1/27,2/18800,0.0028703541270308,0.0161828586127429,0.0078531013548076,MMP12,1
GO:0043113,GO:0043113,receptor clustering,2/27,56/18800,0.002916101570776,0.0163002600622865,0.0079100730867203,APOE/PIGR,2
GO:0002683,GO:0002683,negative regulation of immune system process,4/27,425/18800,0.0029926978162992,0.0166572286966784,0.0080833002608217,ADIPOQ/APCS/APOA1/MMP12,4
GO:0042060,GO:0042060,wound healing,4/27,429/18800,0.0030952241005431,0.0170825026308458,0.008289674140029,APCS/APOE/DCBLD2/MMP12,4
GO:0006695,GO:0006695,cholesterol biosynthetic process,2/27,58/18800,0.0031245491236597,0.0171000429027068,0.0082981859571319,APOA1/APOE,2
GO:1902653,GO:1902653,secondary alcohol biosynthetic process,2/27,58/18800,0.0031245491236597,0.0171000429027068,0.0082981859571319,APOA1/APOE,2
GO:0043407,GO:0043407,negative regulation of MAP kinase activity,2/27,60/18800,0.0033397999960669,0.0181263833811432,0.0087962410903181,ADIPOQ/APOE,2
GO:0046324,GO:0046324,regulation of glucose import,2/27,60/18800,0.0033397999960669,0.0181263833811432,0.0087962410903181,ACE/ADIPOQ,2
GO:0032387,GO:0032387,negative regulation of intracellular transport,2/27,61/18800,0.0034499648524219,0.0184185878651751,0.0089380399828589,ADIPOQ/PCSK9,2
GO:0034113,GO:0034113,heterotypic cell-cell adhesion,2/27,61/18800,0.0034499648524219,0.0184185878651751,0.0089380399828589,ADIPOQ/APOA1,2
GO:0031667,GO:0031667,response to nutrient levels,4/27,446/18800,0.0035579770038985,0.0187857089058609,0.0091161938437422,ACE/ADIPOQ/APOE/PCSK9,4
GO:0010810,GO:0010810,regulation of cell-substrate adhesion,3/27,217/18800,0.0036161889646618,0.0189958841999105,0.0092181862003428,APOA1/MMP12/VWC2,3
GO:0007588,GO:0007588,excretion,2/27,65/18800,0.0039074438649306,0.020281494346545,0.0098420578552765,ACE/NPPB,2
GO:0042445,GO:0042445,hormone metabolic process,3/27,230/18800,0.0042561492671149,0.0207665724532575,0.0100774530736474,ACE/PLA2G7/REN,3
GO:0002018,GO:0002018,renin-angiotensin regulation of aldosterone production,1/27,3/18800,0.0043025543844287,0.0207665724532575,0.0100774530736474,REN,1
GO:0002414,GO:0002414,immunoglobulin transcytosis in epithelial cells,1/27,3/18800,0.0043025543844287,0.0207665724532575,0.0100774530736474,PIGR,1
GO:0070543,GO:0070543,response to linoleic acid,1/27,3/18800,0.0043025543844287,0.0207665724532575,0.0100774530736474,ADIPOQ,1
GO:1902952,GO:1902952,positive regulation of dendritic spine maintenance,1/27,3/18800,0.0043025543844287,0.0207665724532575,0.0100774530736474,APOE,1
GO:1903015,GO:1903015,regulation of exo-alpha-sialidase activity,1/27,3/18800,0.0043025543844287,0.0207665724532575,0.0100774530736474,APCS,1
GO:2000170,GO:2000170,positive regulation of peptidyl-cysteine S-nitrosylation,1/27,3/18800,0.0043025543844287,0.0207665724532575,0.0100774530736474,ACE,1
GO:0016049,GO:0016049,cell growth,4/27,484/18800,0.0047592884370146,0.022719522903705,0.0110251668364189,APOE/DCBLD2/NPPB/RTN4R,4
GO:0048662,GO:0048662,negative regulation of smooth muscle cell proliferation,2/27,73/18800,0.004902163536884,0.0232319924139287,0.0112738543582802,ADIPOQ/APOE,2
GO:0045926,GO:0045926,negative regulation of growth,3/27,245/18800,0.0050754547878406,0.0239664074458321,0.0116302460082382,DCBLD2/NPPB/RTN4R,3
GO:0060284,GO:0060284,regulation of cell development,4/27,500/18800,0.0053383669802039,0.0247609362060524,0.0120158092163605,ACE/ADIPOQ/APOA1/RTN4R,4
GO:0046323,GO:0046323,glucose import,2/27,79/18800,0.0057168275421464,0.0248293639045562,0.0120490153182419,ACE/ADIPOQ,2
GO:0048844,GO:0048844,artery morphogenesis,2/27,79/18800,0.0057168275421464,0.0248293639045562,0.0120490153182419,ANGPTL3/APOE,2
GO:0097018,GO:0097018,renal albumin absorption,1/27,4/18800,0.0057327736232232,0.0248293639045562,0.0120490153182419,ADIPOQ,1
GO:1904045,GO:1904045,cellular response to aldosterone,1/27,4/18800,0.0057327736232232,0.0248293639045562,0.0120490153182419,ACE,1
GO:1905908,GO:1905908,positive regulation of amyloid fibril formation,1/27,4/18800,0.0057327736232232,0.0248293639045562,0.0120490153182419,APOE,1
GO:0003018,GO:0003018,vascular process in circulatory system,3/27,263/18800,0.0061768436173085,0.0266643942291734,0.0129395056495989,ACE/APOE/NPPB,3
GO:0014910,GO:0014910,regulation of smooth muscle cell migration,2/27,83/18800,0.0062920652402159,0.0268954945562172,0.0130516523558659,ACE/ADIPOQ,2
GO:0050886,GO:0050886,endocrine process,2/27,85/18800,0.0065892137003238,0.0279827646754013,0.0135792749873386,ACE/REN,2
GO:0001920,GO:0001920,negative regulation of receptor recycling,1/27,5/18800,0.0071610144783081,0.0292706466800847,0.0142042491132232,PCSK9,1
GO:0060309,GO:0060309,elastin catabolic process,1/27,5/18800,0.0071610144783081,0.0292706466800847,0.0142042491132232,MMP12,1
GO:0060978,GO:0060978,angiogenesis involved in coronary vascular morphogenesis,1/27,5/18800,0.0071610144783081,0.0292706466800847,0.0142042491132232,ACE,1
GO:0072385,GO:0072385,minus-end-directed organelle transport along microtubule,1/27,5/18800,0.0071610144783081,0.0292706466800847,0.0142042491132232,RAB6A,1
GO:2000467,GO:2000467,positive regulation of glycogen (starch) synthase activity,1/27,5/18800,0.0071610144783081,0.0292706466800847,0.0142042491132232,ADIPOQ,1
GO:0051591,GO:0051591,response to cAMP,2/27,89/18800,0.007202389767118,0.0293480554996585,0.0142418135090086,ADIPOQ/REN,2
GO:0002028,GO:0002028,regulation of sodium ion transport,2/27,90/18800,0.0073595908198959,0.0298029250539438,0.014462549338104,PCSK9/PRSS8,2
GO:0014909,GO:0014909,smooth muscle cell migration,2/27,91/18800,0.0075183457670213,0.0302584500408122,0.0146836032308142,ACE/ADIPOQ,2
GO:0001666,GO:0001666,response to hypoxia,3/27,286/18800,0.0077784364949546,0.0312091869184069,0.0151449699917909,ACE/ADIPOQ/FABP1,3
GO:0030516,GO:0030516,regulation of axon extension,2/27,93/18800,0.0078404995742314,0.0313619982969259,0.0152191251996188,APOE/RTN4R,2
GO:0031349,GO:0031349,positive regulation of defense response,3/27,289/18800,0.0080037930287072,0.0319175648827714,0.0154887265606882,ACE/MMP12/PLA2G7,3
GO:0010815,GO:0010815,bradykinin catabolic process,1/27,6/18800,0.0085872795812121,0.0329388905930368,0.0159843481632071,ACE,1
GO:0035931,GO:0035931,mineralocorticoid secretion,1/27,6/18800,0.0085872795812121,0.0329388905930368,0.0159843481632071,REN,1
GO:2000481,GO:2000481,positive regulation of cAMP-dependent protein kinase activity,1/27,6/18800,0.0085872795812121,0.0329388905930368,0.0159843481632071,ADIPOQ,1
GO:0050764,GO:0050764,regulation of phagocytosis,2/27,99/18800,0.0088437940076237,0.0335295146723822,0.0162709619728364,ADIPOQ/APOA1,2
GO:0042158,GO:0042158,lipoprotein biosynthetic process,2/27,101/18800,0.0091903859070412,0.0346427226697694,0.0168111715514815,APOA1/APOE,2
GO:0051702,GO:0051702,biological process involved in interaction with symbiont,2/27,101/18800,0.0091903859070412,0.0346427226697694,0.0168111715514815,APCS/APOE,2
GO:0007162,GO:0007162,negative regulation of cell adhesion,3/27,305/18800,0.009271095343217,0.0348465307727815,0.0169100740833633,ADIPOQ/APOA1/MMP12,3
GO:0022600,GO:0022600,digestive system process,2/27,104/18800,0.0097215540110938,0.0358389711282457,0.0173916784084437,APOA1/FABP1,2
GO:0009744,GO:0009744,response to sucrose,1/27,7/18800,0.0100115715601046,0.0358389711282457,0.0173916784084437,ADIPOQ,1
GO:0023041,GO:0023041,neuronal signal transduction,1/27,7/18800,0.0100115715601046,0.0358389711282457,0.0173916784084437,RTN4R,1
GO:0034285,GO:0034285,response to disaccharide,1/27,7/18800,0.0100115715601046,0.0358389711282457,0.0173916784084437,ADIPOQ,1
GO:1903365,GO:1903365,regulation of fear response,1/27,7/18800,0.0100115715601046,0.0358389711282457,0.0173916784084437,APOE,1
GO:2000822,GO:2000822,regulation of behavioral fear response,1/27,7/18800,0.0100115715601046,0.0358389711282457,0.0173916784084437,APOE,1
GO:0007631,GO:0007631,feeding behavior,2/27,106/18800,0.0100831356079468,0.0358389711282457,0.0173916784084437,ACE/REN,2
GO:0019882,GO:0019882,antigen processing and presentation,2/27,107/18800,0.0102661542936433,0.0361944199894487,0.0175641680779314,ACE/RAB6A,2
GO:0015849,GO:0015849,organic acid transport,3/27,318/18800,0.0103829605601193,0.0365078290662259,0.0177162569828861,ACE/APOE/FABP1,3
GO:0033034,GO:0033034,positive regulation of myeloid cell apoptotic process,1/27,8/18800,0.0114338930397978,0.0380547890484874,0.0184669546082713,ADIPOQ,1
GO:0034498,GO:0034498,early endosome to Golgi transport,1/27,8/18800,0.0114338930397978,0.0380547890484874,0.0184669546082713,RAB6A,1
GO:0045541,GO:0045541,negative regulation of cholesterol biosynthetic process,1/27,8/18800,0.0114338930397978,0.0380547890484874,0.0184669546082713,APOE,1
GO:0045743,GO:0045743,positive regulation of fibroblast growth factor receptor signaling pathway,1/27,8/18800,0.0114338930397978,0.0380547890484874,0.0184669546082713,FGFBP1,1
GO:0090206,GO:0090206,negative regulation of cholesterol metabolic process,1/27,8/18800,0.0114338930397978,0.0380547890484874,0.0184669546082713,APOE,1
GO:0106119,GO:0106119,negative regulation of sterol biosynthetic process,1/27,8/18800,0.0114338930397978,0.0380547890484874,0.0184669546082713,APOE,1
GO:1900223,GO:1900223,positive regulation of amyloid-beta clearance,1/27,8/18800,0.0114338930397978,0.0380547890484874,0.0184669546082713,APOE,1
GO:1904044,GO:1904044,response to aldosterone,1/27,8/18800,0.0114338930397978,0.0380547890484874,0.0184669546082713,ACE,1
GO:2000465,GO:2000465,regulation of glycogen (starch) synthase activity,1/27,8/18800,0.0114338930397978,0.0380547890484874,0.0184669546082713,ADIPOQ,1
GO:0010898,GO:0010898,positive regulation of triglyceride catabolic process,1/27,9/18800,0.0128542466417526,0.0418242651925682,0.0202961789080304,APOA1,1
GO:0051541,GO:0051541,elastin metabolic process,1/27,9/18800,0.0128542466417526,0.0418242651925682,0.0202961789080304,MMP12,1
GO:0060054,GO:0060054,positive regulation of epithelial cell proliferation involved in wound healing,1/27,9/18800,0.0128542466417526,0.0418242651925682,0.0202961789080304,MMP12,1
GO:0046683,GO:0046683,response to organophosphorus,2/27,124/18800,0.0136003561224775,0.0434945374283633,0.0211067166178199,ADIPOQ/REN,2
GO:0051224,GO:0051224,negative regulation of protein transport,2/27,124/18800,0.0136003561224775,0.0434945374283633,0.0211067166178199,ADIPOQ/APOE,2
GO:0051006,GO:0051006,positive regulation of lipoprotein lipase activity,1/27,10/18800,0.01427263498408,0.0444637130482526,0.0215770311991762,APOA1,1
GO:0071838,GO:0071838,cell proliferation in bone marrow,1/27,10/18800,0.01427263498408,0.0444637130482526,0.0215770311991762,ACE,1
GO:1904950,GO:1904950,negative regulation of establishment of protein localization,2/27,128/18800,0.0144447569935229,0.0448782473813014,0.021778193441916,ADIPOQ/APOE,2
GO:0090132,GO:0090132,epithelium migration,3/27,361/18800,0.0145986721377247,0.0452489648249857,0.0219580925394064,APOA1/APOE/FGFBP1,3
GO:0006182,GO:0006182,cGMP biosynthetic process,1/27,11/18800,0.0156890606815481,0.0469594768225741,0.0227881575116789,NPPB,1
GO:0006707,GO:0006707,cholesterol catabolic process,1/27,11/18800,0.0156890606815481,0.0469594768225741,0.0227881575116789,APOE,1
GO:0016127,GO:0016127,sterol catabolic process,1/27,11/18800,0.0156890606815481,0.0469594768225741,0.0227881575116789,APOE,1
GO:0032000,GO:0032000,positive regulation of fatty acid beta-oxidation,1/27,11/18800,0.0156890606815481,0.0469594768225741,0.0227881575116789,FABP1,1
GO:0071872,GO:0071872,cellular response to epinephrine stimulus,1/27,11/18800,0.0156890606815481,0.0469594768225741,0.0227881575116789,ADIPOQ,1
GO:1902033,GO:1902033,regulation of hematopoietic stem cell proliferation,1/27,11/18800,0.0156890606815481,0.0469594768225741,0.0227881575116789,ACE,1
GO:0010977,GO:0010977,negative regulation of neuron projection development,2/27,136/18800,0.0162000650960146,0.0482680755024763,0.0234231848768656,APOE/RTN4R,2
GO:0044282,GO:0044282,small molecule catabolic process,3/27,376/18800,0.0162673749920219,0.048358469294465,0.0234670505267684,ADIPOQ/APOE/FABP1,3
GO:0007586,GO:0007586,digestion,2/27,137/18800,0.0164256336284049,0.0487182058638404,0.0236416209044711,APOA1/FABP1,2
GO:0051384,GO:0051384,response to glucocorticoid,2/27,139/18800,0.0168808292749148,0.0496240939570963,0.0240812237696194,ACE/ADIPOQ,2
GO:0050678,GO:0050678,regulation of epithelial cell proliferation,3/27,382/18800,0.0169639319516069,0.0496240939570963,0.0240812237696194,APOE/FGFBP1/MMP12,3
GO:1900272,GO:1900272,negative regulation of long-term synaptic potentiation,1/27,12/18800,0.0171035263455855,0.0496240939570963,0.0240812237696194,APOE,1
GO:0008584,GO:0008584,male gonad development,2/27,140/18800,0.0171104482986624,0.0496240939570963,0.0240812237696194,ACE/REN,2
